First Manhattan CO Lexicon Pharmaceuticals, Inc. Transaction History

First Manhattan CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.16 $4,110 - $6,646	-1,079 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.12 - $5.87 $4,445 - $6,333	1,079 New	1,079 $4,000
Q3 2019 Nov 13, 2019	SELL	$1.2 - $6.66 $3.54 Million - $19.6 Million	-2,949,979 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$5.35 - $7.11 $1.08 Million - $1.43 Million	201,393 Added 7.33%	2,949,979 $18.6 Million
Q1 2019 Apr 12, 2019	BUY	$4.36 - $7.94 $12 Million - $21.8 Million	2,748,586 New	2,748,586 $15.3 Million
Q2 2018 Aug 01, 2018	SELL	$7.8 - $13.69 $39,000 - $68,450	-5,000 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$12.17 - $16.3 $60,850 - $81,500	5,000	5,000 $61,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.